Agenda

"Excellence in molecular design" symposium on March 14: save the date!

This one-day symposium, co-organized by the Société de Chimie Thérapeutique (SCT), Evotec and the Institut Pasteur, will cover outstanding innovation and applied state-of-the-art molecular design contributing to an advance to drug discovery boundaries. Selected themes of the symposium will be dedicated to "breakthrough" discoveries or innovative technologies/methods and may include the application of machine learning (ML) and artificial intelligence (AI).

This event, part of the Drug Discovery & Screening (ATC-DDS) in the Strategic Plan, will be held on March 14 in the Emile Duclaux lecture hall.

The following speakers have already confirmed their presence:

  •     Dr Christoph Grebner (Sanofi, Frankfurt, Germany)

  •     Dr Raquel Rodriguez Perez (Novartis, Bale, Switzerland)

  •     Dr Fredrick Zetterberg (Galecto Biotech, Copenhagen, Denmark)

  •     Andreas Luttens (University of Uppsala, Uppsala, Sweden), winner of the 2022 Evotec prize for Excellence in Molecular Design.

  •     Dr Stefania Monteleone (Evotec, Abingdon, United Kingdom)

  •     Dr Merveille Eguida (University of Strasbourg, France)

  •     Dr Gilles Labesse (CBS, Montpellier, France)

  •     Drs Christophe Zimmer and Bogdan Ciambur (Institut Pasteur, Paris, France)

Registration is now open (and will be open until March 7 2023).

A precise agenda with titles and abstracts will be available soon.

If you have any questions or require further information, please contact Emilie Boutet: emilie.boutet@pasteur.fr

Find out more
 

 

Print